Colorectal Cancer Trial, Recruiting NCT05689775 Sponsor: Oslo University Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05689775
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with rectal or anal cancer
  • People who are scheduled to have a robot-assisted surgery to remove the rectum and surrounding tissue (a procedure called abdominoperineal resection)
  • People whose surgery plan includes rebuilding the pelvic floor and/or vagina using a section of muscle taken from the abdomen (called a rectus abdominis muscle flap)

Who may not be able to join:

  • People whose health or other factors mean the surgical team has determined they are not suitable for the robot-assisted version of this surgery
  • People for whom the abdominal muscle needed for the reconstruction is not available to be used
  • People whose surgical wound is not considered suitable for repair using this type of abdominal muscle flap

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lars Frich, MD, PhD, Oslo University Hospital

Phone: 004722930000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
31 December 2024

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Perineal wound healing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov